Trademark Search > Trademark Owners > P > Pfizer Inc.

Pfizer Inc. Trademarks (3362 records)

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners listed on this page.

Company Trademark Status Update Alerts are email updates of the latest trademarks' status change on company level. Click here to get the alert for FREE!

Page 1 of 169

Goods and Services: Providing online non-downloadable videos featuring information regarding eczema and the treat...
LIVE (Circa: 2020)

ECZEMA CONVO

Goods and Services: Providing online non-downloadable videos featuring information regarding eczema and the treat...
LIVE (Circa: 2020)

#ECZEMACONVO

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

REVEMBEQ

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

DURVEQTIX

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

AMSPARITY

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

ABRILADA

Goods and Services: Providing information about health care costs through a website; providing an interactive web...
LIVE (Circa: 2020)

PFIZER INFORM

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

GEXTEVVIX

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

VEQZACT

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

GEXTRAVIX

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

BONVEQTIX

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

MYGEVETIX

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

MYGEVITIX

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

ORDAVVEQ

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

GEMODYVEQ

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

GEMODIVEQ

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

MYVEQDYS

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

TARVEQDYS

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

VEQTRANDYS

Goods and Services: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous ...
LIVE (Circa: 2020)

COVLINIC

Hot News! On Monday, April 27, 2020, a U.S. federal trademark registration number 88889840 was filed for ABRYNTA by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Hot News! On Thursday, April 30, 2020, a U.S. federal trademark registration number 88895897 was filed for COVLINIC by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Hot News! On Thursday, April 30, 2020, a U.S. federal trademark registration number 88895919 was filed for SOTERINIM by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Hot News! On Thursday, April 30, 2020, a U.S. federal trademark registration number 88895922 was filed for TECLIVO by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Hot News! On Tuesday, May 5, 2020, a U.S. federal trademark registration number 88900992 was filed for GEXTEVVIX by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Hot News! On Tuesday, May 5, 2020, a U.S. federal trademark registration number 88900994 was filed for VEQZACT by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Hot News! On Tuesday, May 5, 2020, a U.S. federal trademark registration number 88900997 was filed for GEXTRAVIX by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Hot News! On Tuesday, May 5, 2020, a U.S. federal trademark registration number 88901001 was filed for BONVEQTIX by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Hot News! On Tuesday, May 5, 2020, a U.S. federal trademark registration number 88901030 was filed for MYGEVETIX by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Hot News! On Tuesday, May 5, 2020, a U.S. federal trademark registration number 88901039 was filed for MYGEVITIX by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Hot News! On Tuesday, May 5, 2020, a U.S. federal trademark registration number 88902180 was filed for ORDAVVEQ by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of muscular dystrophy.

Hot News! On Tuesday, May 5, 2020, a U.S. federal trademark registration number 88902183 was filed for GEMODYVEQ by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of muscular dystrophy.

Hot News! On Tuesday, May 5, 2020, a U.S. federal trademark registration number 88902185 was filed for GEMODIVEQ by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of muscular dystrophy.

Hot News! On Tuesday, May 5, 2020, a U.S. federal trademark registration number 88902186 was filed for MYVEQDYS by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of muscular dystrophy.

Hot News! On Tuesday, May 5, 2020, a U.S. federal trademark registration number 88902188 was filed for TARVEQDYS by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of muscular dystrophy.

Hot News! On Tuesday, May 5, 2020, a U.S. federal trademark registration number 88902220 was filed for VEQTRANDYS by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of muscular dystrophy.

Hot News! On Wednesday, May 6, 2020, a U.S. federal trademark registration number 88903977 was filed for PFIZER INFORM by Pfizer Inc. with the description Providing information about health care costs through a website; providing an interactive website featuring information regarding health care costs.

Hot News! On Friday, May 8, 2020, a U.S. federal trademark registration number 88907939 was filed for AMSPARITY by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Hot News! On Friday, May 8, 2020, a U.S. federal trademark registration number 88907943 was filed for ABRILADA by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Hot News! On Thursday, May 14, 2020, a U.S. federal trademark registration number 88916001 was filed for REVEMBEQ by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Hot News! On Thursday, May 14, 2020, a U.S. federal trademark registration number 88916002 was filed for DURVEQTIX by Pfizer Inc. with the description Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Hot News! On Friday, May 15, 2020, a U.S. federal trademark registration number 88918760 was filed for ECZEMA CONVO by Pfizer Inc. with the description Providing online non-downloadable videos featuring information regarding eczema and the treatment of eczema.

Hot News! On Friday, May 15, 2020, a U.S. federal trademark registration number 88918821 was filed for #ECZEMACONVO by Pfizer Inc. with the description Providing online non-downloadable videos featuring information regarding eczema and the treatment of eczema.